SRX246

· Azevan Pharmaceuticals

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for SRX246, covering 2010-03-17 to 2023-07-20. Get the full timeline:

Most recent: Clinical Trial Update: Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease [Phase 2]